CME
Latest Episodes
Gene- and Nano-Therapy for PAH: Could This Be the Future?
Host: Sudarshan Rajagopal, MD, PhD While there are now many effective drug treatments for PAH and PH, new molecular pathways of disease offer horizons for novel therapeutic developments that may, alone or in combination with existing, approved m
The Role of Inhaled Treprostinil For Treatment of PH-ILD
Host: Oksana A. Shlobin, MD While there are now many effective drug treatments for PAH and PH, new molecular pathways of disease offer horizons for novel therapeutic developments that may, alone or in combination with existing, approved medicati
Imatinib for Group 1 PAH
Host: Oksana A. Shlobin, MD While there are now many effective drug treatments for PAH and PH, new molecular pathways of disease offer horizons for novel therapeutic developments that may, alone or in combination with existing, approved medicati
Emerging Therapeutics: The Potential of Targeting the Serotonin Pathway in PAH
Host: Sudarshan Rajagopal, MD, PhD While there are now many effective drug treatments for PAH and PH, new molecular pathways of disease offer horizons for novel therapeutic developments that may, alone or in combination with existing, approved m
Emerging PH Therapeutics: Vardenafil
Host: Ioana Preston, MD While there are now many effective drug treatments for PAH and PH, new molecular pathways of disease offer horizons for novel therapeutic developments that may, alone or in combination with existing, approved medications,
Sotatercept: A Novel Entity with Promising Potential for Treating PAH
Host: Ioana Preston, MD While there are now many effective drug treatments for PAH and PH, new molecular pathways of disease offer horizons for novel therapeutic developments that may, alone or in combination with existing, approved medications,
Emerging Novel PH Therapies: Will They Impact Treatment Strategies?
Host: Sudarshan Rajagopal, MD, PhD Host: Oksana A. Shlobin, MD Host: Rajan Saggar, MD While there are now many effective drug treatments for PAH and PH, new molecular pathways of disease offer horizons for novel therapeutic developments
The Future of Muscular Dystrophy Management: Updates for Duchenne Muscular Dystrophy
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Julie Parsons, MD Guest: Craig Zaidman, MD Duchenne Muscular Dystrophy, or DMD, is considered a rare disease, affecting 1 in 3,500 boy births. But to the patients afflicted-and
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Closing Module
Host: James Galvin, MD, MPH, FANA Guest: Gloria Chiang, MD Guest: Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF Guest: Charles P. Vega, MD Recently, Alzheimers Disease (AD) saw its first approvals for disease modifying therapy
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Emergency Medicine Module
Host: James Galvin, MD, MPH, FANA Guest: Gloria Chiang, MD Guest: Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF Recently, Alzheimers Disease (AD) saw its first approvals for disease modifying therapy (DMT). With amyloid-beta (A) t
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast